Pharmacogenomics at the post-pandemic: If not now, then when?

Zeina N. Al-Mahayri

doi:10.3389/fphar.2022.1013527

Pharmacogenomics at the post-pandemic: If not now, then when?

Zeina N. Al-Mahayri

United Arab Emirates University

Research output: Contribution to journal › Comment/debate

Original language	English
Article number	1013527
Journal	Frontiers in Pharmacology
Volume	13
DOIs	https://doi.org/10.3389/fphar.2022.1013527
State	Published - 26 Sep 2022

Keywords

COVID-19
cost-effective
pharmacogenomics (PGx)
precision medicine
understudied groups

Access to Document

10.3389/fphar.2022.1013527

Cite this

@article{63d3643330124b38a39fb10bd173f2f7,

title = "Pharmacogenomics at the post-pandemic: If not now, then when?",

keywords = "COVID-19, cost-effective, pharmacogenomics (PGx), precision medicine, understudied groups",

author = "Al-Mahayri, \{Zeina N.\}",

year = "2022",

month = sep,

day = "26",

doi = "10.3389/fphar.2022.1013527",

language = "English",

volume = "13",

journal = "Frontiers in Pharmacology",

issn = "1663-9812",

publisher = "Frontiers Media S.A.",

}

TY - JOUR

T1 - Pharmacogenomics at the post-pandemic

T2 - If not now, then when?

AU - Al-Mahayri, Zeina N.

PY - 2022/9/26

Y1 - 2022/9/26

KW - COVID-19

KW - cost-effective

KW - pharmacogenomics (PGx)

KW - precision medicine

KW - understudied groups

UR - https://www.scopus.com/pages/publications/85139549183

U2 - 10.3389/fphar.2022.1013527

DO - 10.3389/fphar.2022.1013527

M3 - Comment/debate

AN - SCOPUS:85139549183

SN - 1663-9812

VL - 13

JO - Frontiers in Pharmacology

JF - Frontiers in Pharmacology

M1 - 1013527

ER -

Pharmacogenomics at the post-pandemic: If not now, then when?

Keywords

Access to Document

Other files and links

Cite this